Project: Drug substance development for pain reduction
The project aims to develop a new, more effective technology for synthesizing an active pharmaceutical ingredient (API) for a drug used primarily as a pain reliever for moderate to severe pain. The API is used in both human and veterinary pharmaceuticals. Its current uses include treatment for migraines, post-surgery pain relief, and chronic pain relief.
The project budget is 249 208 EUR, of which 60% is co-financed by the Estonian Business and Innovation Agency. Project period: from January 1st to August 31th 2023.
